Ferroptosis: A New Therapeutic Target for Bladder Cancer

Overview

Journal Front Pharmacol

Date 2022 Nov 21

PMID 36408230

Authors

Fan Zeng

Yunping Lan

Ning Wang

Xiaobo Huang

Qiao Zhou

Yi Wang

Affiliations

Soon will be listed here.

Abstract

Bladder cancer (BC) is the most frequent type of urinary system cancer. The prognosis of BC is poor due to high metastasis rates and multidrug resistance. Hence, development of novel therapies targeting BC cell death is urgently needed. As a novel cell death type with strong antitumor potential, ferroptosis has been investigated by many groups for its potential in BC treatment. As an iron-dependent cell death process, ferroptosis is characterized by excessive oxidative phospholipids. The molecular mechanisms of ferroptosis include iron overload and the system Xc-GSH-GPX4 signaling pathway. A recent study revealed that ferroptosis is involved in the metastasis, treatment, and prognosis of BC. Herein, in this review, we comprehensively summarize the mechanism of ferroptosis, address newly identified targets involved in ferroptosis, and discuss the potential of new clinical therapies targeting ferroptosis in BC.

Citing Articles

Methyltransferase-like 7B participates in bladder cancer via ACSL3 mA modification in a ferroptosis manner.

He J, Dong C, Song X, Qiu Z, Zhang H, Jiang Y Biol Direct. 2025; 20(1):9.

PMID: 39833962 PMC: 11744867. DOI: 10.1186/s13062-025-00597-z.

Silencing CCT3 induces ferroptosis through the NOD1-NF-κB signaling pathway in bladder cancer.

Huang J, Luo Y, Wang Y, Wang S, Huang R, An Y Sci Rep. 2024; 14(1):26188.

PMID: 39478031 PMC: 11525567. DOI: 10.1038/s41598-024-76724-z.

Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies.

Ma W, Jiang X, Jia R, Li Y Cell Death Discov. 2024; 10(1):432.

PMID: 39384767 PMC: 11464522. DOI: 10.1038/s41420-024-02195-w.

Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.

Wu P, Zhao L, Kong G, Song B Technol Cancer Res Treat. 2024; 23:15330338241246649.

PMID: 38656249 PMC: 11044785. DOI: 10.1177/15330338241246649.

Exploration of potential biomarkers for early bladder cancer based on urine proteomics.

Zhou X, Xue F, Li T, Xue J, Yue S, Zhao S Front Oncol. 2024; 14:1309842.

PMID: 38410113 PMC: 10894981. DOI: 10.3389/fonc.2024.1309842.

References

Guan Z, Chen J, Li X, Dong N . Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 2020; 40(8). PMC: 7953492. DOI: 10.1042/BSR20201807. View

Hu J, Zhang R, Chang Q, Ji M, Zhang H, Geng R . p53: A Regulator of Ferroptosis Induced by Galectin-1 Derived Peptide 3 in MH7A Cells. Front Genet. 2022; 13:920273. PMC: 9289366. DOI: 10.3389/fgene.2022.920273. View

Seibt T, Proneth B, Conrad M . Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2018; 133:144-152. DOI: 10.1016/j.freeradbiomed.2018.09.014. View

Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y . LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis. 2021; 12(11):1043. PMC: 8563982. DOI: 10.1038/s41419-021-04296-1. View

Maiorino M, Conrad M, Ursini F . GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues. Antioxid Redox Signal. 2017; 29(1):61-74. DOI: 10.1089/ars.2017.7115. View

Zhou H, Zhou Y, Mao J, Tang L, Xu J, Wang Z . NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells. Redox Biol. 2022; 55:102413. PMC: 9356278. DOI: 10.1016/j.redox.2022.102413. View

Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J . The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020; 36:101619. PMC: 7330619. DOI: 10.1016/j.redox.2020.101619. View

Santana-Codina N, Gikandi A, Mancias J . The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis. Adv Exp Med Biol. 2021; 1301:41-57. DOI: 10.1007/978-3-030-62026-4_4. View

Takashi Y, Tomita K, Kuwahara Y, Roudkenar M, Roushandeh A, Igarashi K . Mitochondrial dysfunction promotes aquaporin expression that controls hydrogen peroxide permeability and ferroptosis. Free Radic Biol Med. 2020; 161:60-70. PMC: 7530583. DOI: 10.1016/j.freeradbiomed.2020.09.027. View

10.

Guo P, Wang L, Shang W, Chen J, Chen Z, Xiong F . Intravesical Immunostimulatory Gel for Triple Therapy of Bladder Cancer. ACS Appl Mater Interfaces. 2020; 12(49):54367-54377. DOI: 10.1021/acsami.0c15176. View

11.

Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

12.

Chen J, Li T, Cheng L, Qin T, Sun Y, Chen C . Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives. Eur J Med Chem. 2020; 205:112661. DOI: 10.1016/j.ejmech.2020.112661. View

13.

Hou J, Lu Z, Cheng X, Dong R, Jiang Y, Wu G . Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer. BMC Cancer. 2022; 22(1):719. PMC: 9245204. DOI: 10.1186/s12885-022-09805-9. View

14.

Mendiratta G, Ke E, Aziz M, Liarakos D, Tong M, Stites E . Cancer gene mutation frequencies for the U.S. population. Nat Commun. 2021; 12(1):5961. PMC: 8514428. DOI: 10.1038/s41467-021-26213-y. View

15.

Liao M, Huang T, Chin Y, Cheng T, Lin G . Surfactant-Free Green Synthesis of Au@Chlorophyll Nanorods for NIR PDT-Elicited CDT in Bladder Cancer Therapy. ACS Appl Bio Mater. 2022; 5(6):2819-2833. DOI: 10.1021/acsabm.2c00228. View

16.

Liu Y, Tavana O, Gu W . p53 modifications: exquisite decorations of the powerful guardian. J Mol Cell Biol. 2019; 11(7):564-577. PMC: 6736412. DOI: 10.1093/jmcb/mjz060. View

17.

Chen G, Song C, Pantopoulos K, Wei X, Zheng H, Luo Z . Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radic Biol Med. 2022; 180:95-107. DOI: 10.1016/j.freeradbiomed.2022.01.012. View

18.

Liu J, Kang R, Tang D . Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2021; 289(22):7038-7050. DOI: 10.1111/febs.16059. View

19.

Wang F, Min J . DHODH tangoing with GPX4 on the ferroptotic stage. Signal Transduct Target Ther. 2021; 6(1):244. PMC: 8212586. DOI: 10.1038/s41392-021-00656-7. View

20.

Doll S, Proneth B, Tyurina Y, Panzilius E, Kobayashi S, Ingold I . ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2016; 13(1):91-98. PMC: 5610546. DOI: 10.1038/nchembio.2239. View